English
Segment disclosures
Company overviewVerrica Pharmaceuticals Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
8 dimension combinations 55 retained observations 12 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Product · Operating Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=vrca:OperatingSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 15285000 | USD | 20260311 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3607000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 11563000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 6574000 | USD | 20260311 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -1865000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6259000 | USD | 20251114 | Open filing evidence |
Product · Reportable Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=vrca:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 5093000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 9383000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 4290000 | USD | 20260512 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 4534000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 7956000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 3422000 | USD | 20260512 | Open filing evidence |
License And Collaboration Revenue · Operating Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=vrca:LicenseAndCollaborationRevenueMember;us-gaap:StatementBusinessSegmentsAxis=vrca:OperatingSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 20292000 | USD | 20260311 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 10737000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 18922000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 992000 | USD | 20260311 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 84000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 963000 | USD | 20251114 | Open filing evidence |
License And Collaboration Revenue · Reportable Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=vrca:LicenseAndCollaborationRevenueMember;us-gaap:StatementBusinessSegmentsAxis=vrca:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 769000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1502000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 733000 | USD | 20260512 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 8168000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8185000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 17000 | USD | 20260512 | Open filing evidence |
Operating Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=vrca:OperatingSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 35577000 | USD | 20260311 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 14344000 | USD | 20251114 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 30485000 | USD | 20251114 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 12702000 | USD | 20250812 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 16141000 | USD | 20250812 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 3439000 | USD | 20250513 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 7566000 | USD | 20260311 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | -1781000 | USD | 20251114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 7222000 | USD | 20251114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5177000 | USD | 20250812 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 9003000 | USD | 20250812 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 3826000 | USD | 20250513 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 5124000 | USD | 20250311 | Open filing evidence |
Reportable Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=vrca:ReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 6914000 | USD | 20261113 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 17799000 | USD | 20261113 | Open filing evidence |
| 2026-04-01 – 2026-06-30 | 5862000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 10885000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 5023000 | USD | 20260512 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 14344000 | USD | 20261113 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 30485000 | USD | 20261113 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 12702000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 16141000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 3439000 | USD | 20260512 | Open filing evidence |
Reportable Segment · Product
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=vrca:ReportableSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 5697000 | USD | 20261113 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 15080000 | USD | 20261113 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3607000 | USD | 20261113 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 11563000 | USD | 20261113 | Open filing evidence |
Reportable Segment · License And Collaboration Revenue
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=vrca:ReportableSegmentMember;srt:ProductOrServiceAxis=vrca:LicenseAndCollaborationRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 1217000 | USD | 20261113 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 2719000 | USD | 20261113 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 10737000 | USD | 20261113 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 18922000 | USD | 20261113 | Open filing evidence |